NanoViricides Cost Of Revenue vs Income Before Tax Analysis
NNVC Stock | USD 2.07 0.16 7.17% |
NanoViricides financial indicator trend analysis is infinitely more than just investigating NanoViricides recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether NanoViricides is a good investment. Please check the relationship between NanoViricides Cost Of Revenue and its Income Before Tax accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NanoViricides. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. For information on how to trade NanoViricides Stock refer to our How to Trade NanoViricides Stock guide.
Cost Of Revenue vs Income Before Tax
Cost Of Revenue vs Income Before Tax Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of NanoViricides Cost Of Revenue account and Income Before Tax. At this time, the significance of the direction appears to have weak relationship.
The correlation between NanoViricides' Cost Of Revenue and Income Before Tax is 0.37. Overlapping area represents the amount of variation of Cost Of Revenue that can explain the historical movement of Income Before Tax in the same time period over historical financial statements of NanoViricides, assuming nothing else is changed. The correlation between historical values of NanoViricides' Cost Of Revenue and Income Before Tax is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cost Of Revenue of NanoViricides are associated (or correlated) with its Income Before Tax. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Income Before Tax has no effect on the direction of Cost Of Revenue i.e., NanoViricides' Cost Of Revenue and Income Before Tax go up and down completely randomly.
Correlation Coefficient | 0.37 |
Relationship Direction | Positive |
Relationship Strength | Very Weak |
Cost Of Revenue
Cost of Revenue is found on NanoViricides income statement and represents the costs associated with goods and services NanoViricides provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.Income Before Tax
Income Before Tax which can also be referred as pre-tax income is reported on NanoViricides income statement and is an important metric when analyzing NanoViricides profitability. Accounting techniques because taxes can be complex, and not perfectly consistent from one company to company, an analyst may use pre-tax income as a more stable measure of profitability.Most indicators from NanoViricides' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into NanoViricides current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NanoViricides. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. For information on how to trade NanoViricides Stock refer to our How to Trade NanoViricides Stock guide.At present, NanoViricides' Issuance Of Capital Stock is projected to increase significantly based on the last few years of reporting.
2021 | 2022 | 2023 | 2024 (projected) | Reconciled Depreciation | 723.3K | 747.5K | 859.7K | 772.2K | Interest Income | 11.9K | 355.8K | 409.2K | 429.7K |
NanoViricides fundamental ratios Correlations
Click cells to compare fundamentals
NanoViricides Account Relationship Matchups
High Positive Relationship
High Negative Relationship
NanoViricides fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Other Current Liab | 630.8K | 55.8K | 260.1K | 377.2K | 433.8K | 618.7K | |
Total Current Liabilities | 2.2M | 351.1K | 412.8K | 534.3K | 614.4K | 583.7K | |
Total Stockholder Equity | 21.8M | 29.9M | 23.1M | 14.9M | 17.1M | 15.3M | |
Retained Earnings | (105.6M) | (114.4M) | (122.5M) | (131.1M) | (118.0M) | (112.1M) | |
Accounts Payable | 380.7K | 200.0K | 58.0K | 157.1K | 141.4K | 274.0K | |
Common Stock Total Equity | 69.2K | 76.9K | 9.1K | 11.5K | 10.4K | 9.8K | |
Common Stock Shares Outstanding | 5.6M | 10.9M | 11.5M | 11.6M | 13.4M | 14.0M | |
Other Stockholder Equity | 127.3M | 144.3M | 145.6M | 145.9M | 167.8M | 176.2M | |
Total Liab | 2.2M | 351.1K | 412.8K | 2.0M | 2.3M | 4.3M | |
Common Stock | 9.1K | 11.5K | 11.6K | 116.0 | 104.4 | 99.18 | |
Total Assets | 23.9M | 30.3M | 23.5M | 16.9M | 19.4M | 20.7M | |
Property Plant And Equipment Net | 9.5M | 9.1M | 8.7M | 8.1M | 9.3M | 6.2M | |
Net Debt | (12.6M) | (20.4M) | (14.0M) | (8.1M) | (7.3M) | (7.7M) | |
Cash | 13.7M | 20.5M | 14.1M | 8.1M | 9.4M | 13.7M | |
Non Current Assets Total | 9.9M | 9.4M | 9.1M | 8.5M | 9.7M | 6.7M | |
Non Currrent Assets Other | 25.9K | 3.5K | 42.4K | 14.4K | 12.9K | 12.3K | |
Cash And Short Term Investments | 13.7M | 20.5M | 14.1M | 8.1M | 9.4M | 13.7M | |
Liabilities And Stockholders Equity | 23.9M | 30.3M | 23.5M | 16.9M | 19.4M | 20.7M | |
Non Current Liabilities Total | 1.5M | 295.3K | 152.7K | 1.5M | 1.4M | 1.3M | |
Other Current Assets | 277.1B | 307.1B | 350.0K | 295.5K | 339.8K | 322.8K | |
Property Plant And Equipment Gross | 9.5M | 9.1M | 14.7M | 14.8M | 17.0M | 17.9M | |
Total Current Assets | 14.0M | 20.8M | 14.4M | 8.4M | 9.7M | 14.1M | |
Intangible Assets | 358.4K | 350.1K | 341.8K | 333.6K | 383.6K | 357.5K | |
Property Plant Equipment | 9.5M | 9.1M | 8.7M | 8.1M | 9.3M | 8.4M | |
Net Tangible Assets | 21.4M | 29.6M | 22.7M | 14.5M | 16.7M | 22.0M | |
Net Invested Capital | 22.9M | 30.0M | 23.2M | 14.9M | 17.1M | 22.5M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.C | Citigroup | |
CRM | Salesforce | |
MSFT | Microsoft |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NanoViricides. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. For information on how to trade NanoViricides Stock refer to our How to Trade NanoViricides Stock guide.You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Complementary Tools for NanoViricides Stock analysis
When running NanoViricides' price analysis, check to measure NanoViricides' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NanoViricides is operating at the current time. Most of NanoViricides' value examination focuses on studying past and present price action to predict the probability of NanoViricides' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NanoViricides' price. Additionally, you may evaluate how the addition of NanoViricides to your portfolios can decrease your overall portfolio volatility.
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Transaction History View history of all your transactions and understand their impact on performance | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data |
Is NanoViricides' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NanoViricides. If investors know NanoViricides will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NanoViricides listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.80) | Return On Assets (0.36) | Return On Equity (0.58) |
The market value of NanoViricides is measured differently than its book value, which is the value of NanoViricides that is recorded on the company's balance sheet. Investors also form their own opinion of NanoViricides' value that differs from its market value or its book value, called intrinsic value, which is NanoViricides' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NanoViricides' market value can be influenced by many factors that don't directly affect NanoViricides' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NanoViricides' value and its price as these two are different measures arrived at by different means. Investors typically determine if NanoViricides is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NanoViricides' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.